Theodosia Teo

849 citations

25 papers · 692 indexed · h-index 15

Oncology top 10%
- Cancer-related Molecular Pathways 11
Molecular Biology
- PI3K/AKT/mTOR signaling in cancer 9
- Protein Degradation and Inhibitors 6
- Protein Kinase Regulation and GTPase Signaling 4
- Ubiquitin and proteasome pathways 3
Genetics
Organic Chemistry top 10%
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 7
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 5
Cell Biology
- Microtubule and mitosis dynamics 3

Co-authors: Shudong Wang Mingfeng Yu Malika Kumarasiri Robert Milne Sarah Diab Frankie Lam Matthew J. Sykes Sunita K. C. Basnet
Cited by: Oncology Molecular Biology Genetics
Journals: Journal of Medicinal Chemistry (3 papers)Molecules (1 paper)Molecular Pharmacology (2 papers)
Partner nations: Australia United Kingdom China

In The Last Decade

Theodosia Teo

24 papers receiving 688 citations

Peers

Countries citing papers authored by Theodosia Teo

Since Specialization

Citations

This map shows the geographic impact of Theodosia Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodosia Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodosia Teo more than expected).

Fields of papers citing papers by Theodosia Teo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodosia Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodosia Teo. The network helps show where Theodosia Teo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Theodosia Teo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Theodosia Teo Line = papers co-authored together Theodosia Teo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma Biomedicine & Pharmacotherapy ·Laychiluh Mekonnen,Theodosia Teo,Benjamin Noll,Muhammed H. Rahaman,Jimma Likisa Lenjisa,Sunita K. C. Basnet,Ramin Hassankhani,Robert Milne,Briony L. Gliddon,Melinda N. Tea,Stuart M. Pitson,Yan Zhou,Lijun Wei,Hui Wang,Jun Liu,Xiang Zhou,Ke Wang,Shudong Wang	2025	0
2	Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation Molecules ·Biruk Sintayehu Fanta,Jimma Likisa Lenjisa,Theodosia Teo,Lianmeng Kou,Laychiluh Mekonnen,Yuchao Yang,Sunita K. C. Basnet,Ramin Hassankhani,Matthew J. Sykes,Mingfeng Yu,Shudong Wang	2023	6
3	2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluation Bioorganic & Medicinal Chemistry ·Biruk Sintayehu Fanta,Laychiluh Mekonnen,Sunita K. C. Basnet,Theodosia Teo,Jimma Likisa Lenjisa,Nishat Zareen Khair,Lianmeng Kou,Solomon Tadesse,Matthew J. Sykes,Mingfeng Yu,Shudong Wang	2023	13
4	An overview of CDK3 in cancer: clinical significance and pharmacological implications Pharmacological Research ·Theodosia Teo,Sara Kasirzadeh,Hugo Albrecht,Matthew J. Sykes,Yuchao Yang,Shudong Wang	2022	10
5	Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation European Journal of Medicinal Chemistry ·Mingfeng Yu,Long Yi,Yuchao Yang,Manjun Li,Theodosia Teo,Benjamin Noll,Stephen Philip,Shudong Wang	2021	9
6	Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation European Journal of Medicinal Chemistry ·Mingfeng Yu,Theodosia Teo,Yuchao Yang,Manjun Li,Long Yi,Stephen Philip,Benjamin Noll,Gary K. Heinemann,Sarah Diab,Preethi Eldi,Laychiluh Mekonnen,Abel Tesfaye Anshabo,Muhammed H. Rahaman,Robert Milne,John D. Hayball,Shudong Wang	2021	14
7	CDK12: a potential therapeutic target in cancer Drug Discovery Today ·Fatemeh Emadi,Theodosia Teo,Muhammed H. Rahaman,Shudong Wang	2020	25
8	Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia European Journal of Medicinal Chemistry ·Sarah Diab,Ahmad M. Abdelaziz,Peng Li,Theodosia Teo,Sunita K. C. Basnet,Ben Noll,Muhammed H. Rahaman,Jingfeng Lu,Jinqiang Hou,Mingfeng Yu,Bich Thuy Le,Hugo Albrecht,Robert Milne,Shudong Wang	2017	23
9	Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy? Journal of Medicinal Chemistry ·Stephen Philip,Malika Kumarasiri,Theodosia Teo,Mingfeng Yu,Shudong Wang	2017	82
10	Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation European Journal of Medicinal Chemistry ·Mingfeng Yu,Peng Li,Sunita K. C. Basnet,Malika Kumarasiri,Sarah Diab,Theodosia Teo,Hugo Albrecht,Shudong Wang	2015	31
11	An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis European Journal of Medicinal Chemistry ·Theodosia Teo,Yuchao Yang,Mingfeng Yu,Sunita K. C. Basnet,Todd A. Gillam,Jinqiang Hou,Raffaella M. Schmid,Malika Kumarasiri,Sarah Diab,Hugo Albrecht,Matthew J. Sykes,Shudong Wang	2015	23
12	Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2 Molecular Pharmacology ·Sunita K. C. Basnet,Sarah Diab,Raffaella M. Schmid,Mingfeng Yu,Yuchao Yang,Todd A. Gillam,Theodosia Teo,Peng Li,Thomas S. Peat,Hugo Albrecht,Shudong Wang	2015	14
13	Pharmacologic Inhibition of MNKs in Acute Myeloid Leukemia Molecular Pharmacology ·Theodosia Teo,Frankie Lam,Mingfeng Yu,Yuchao Yang,Sunita K. C. Basnet,Hugo Albrecht,Matthew J. Sykes,Shudong Wang	2015	27
14	Dynamical Insights of Mnk2 Kinase Activation by Phosphorylation to Facilitate Inhibitor Discovery Future Medicinal Chemistry ·Malika Kumarasiri,Theodosia Teo,Shudong Wang	2015	6
15	MAP Kinase-Interacting Kinases—Emerging Targets against Cancer Chemistry & Biology ·Sarah Diab,Malika Kumarasiri,Mingfeng Yu,Theodosia Teo,Christopher G. Proud,Robert Milne,Shudong Wang	2014	79
16	Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells Cancer Letters ·Theodosia Teo,Mingfeng Yu,Yuchao Yang,Todd A. Gillam,Frankie Lam,Matthew J. Sykes,Shudong Wang	2014	38
17	Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3H)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation ChemMedChem ·Sarah Diab,Theodosia Teo,Malika Kumarasiri,Peng Li,Mingfeng Yu,Frankie Lam,Sunita K. C. Basnet,Matthew J. Sykes,Hugo Albrecht,Robert Milne,Shudong Wang	2014	71
18	Discovery of (E)-3-((Styrylsulfonyl)methyl)pyridine and (E)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities Journal of Medicinal Chemistry ·Tiangong Lu,Aik Wye Goh,Mingfeng Yu,Julian Adams,Frankie Lam,Theodosia Teo,Peng Li,Ben Noll,Long‐Jin Zhong,Sarah Diab,Osama Chahrour,Anran Hu,Abdullahi Y. Abbas,Xiangrui Liu,Shi‐Liang Huang,Christopher J. Sumby,Robert Milne,Carol Midgley,Shudong Wang	2014	27
19	Insights into the Importance of DFD-Motif and Insertion I1 in Stabilizing the DFD-Out Conformation of Mnk2 Kinase ACS Medicinal Chemistry Letters ·Jinqiang Hou,Theodosia Teo,Matthew J. Sykes,Shudong Wang	2013	11
20	Identification of a Novel Oligomerization Disrupting Mutation inCRYΑAAssociated with Congenital Cataract in a South Australian Family Human Mutation ·Kate J. Laurie,Alpana Dave,Tania Straga,Emmanuelle Souzeau,Tim Chataway,Matthew J. Sykes,Theresa Casey,Theodosia Teo,John Pater,Jamie E. Craig,Shiwani Sharma,Kathryn P. Burdon	2012	27

About Theodosia Teo

Theodosia Teo is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics, having authored 25 papers that have together received 692 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Mechanisms and Therapy (7 papers), Protein Degradation and Inhibitors (6 papers), Advanced Breast Cancer Therapies (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Ubiquitin and proteasome pathways (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Oncology (241 citations), Molecular Biology (438 citations) and Genetics (65 citations). Theodosia Teo has collaborated with scholars based in Australia, United Kingdom and China. Frequent co-authors include Shudong Wang, Mingfeng Yu, Malika Kumarasiri, Robert Milne, Sarah Diab, Frankie Lam, Matthew J. Sykes, Sunita K. C. Basnet, Hugo Albrecht and Yuchao Yang. Their work appears in journals such as Journal of Medicinal Chemistry, Molecules and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact